Fish Attorneys Author Part Two of a Four-Part Series in Biosimilar Development, "Biosimilar Litigation Review: BPCIA Cases Settled Or Dismissed In 2019"


Part two of a four-part series on 2019 legal developments related to the biosimilar sector is now available. Written by Fish principal Jenny Shmuel and associates Philip Chen and Felix Eyzaguirre, this article focuses on Biosimilars Price Competition and Innovation Act (BPCIA) cases settled or dismissed in 2019.

Click here to read “Biosimilar Litigation Review: BPCIA Cases Settled or Dismissed in 2019”

Authors: Philip Chen, Felix Eyzaguirre, Tasha Francis, Jenny Shmuel